Clinical trial
To Evaluate the Clinical Efficacy of Probiotic in Patients With NAFLD
NCT05402449 is registered in ClinicalTrials.gov with GenMont Biotech Incorporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Evaluate the Clinical Efficacy of Probiotic in Patients With NAFLD
- Lead sponsor
- GenMont Biotech Incorporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 14, 2022
- Completion date
- May 31, 2024
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.